In With The Old? 2013 To Mark Rebirth Of CDER’s Pharmacy Compounding, Medical Imaging AdComms

Two Center for Drug Evaluation and Research advisory committees that were eliminated a decade ago appear primed to make a comeback in 2013, with the agency hinting it will resuscitate its Pharmacy Compounding Drugs Advisory Committee in the new year and the inaugural meeting of the newly re-formed Medical Imaging Drugs Advisory Committee set for February.

Re-establishment of a compounding drugs panel, which was dissolved in 2002, would give the agency a scientific public forum, and perhaps some political cover, for addressing issues such as quality control and drug shortages that have received widespread attention with the